Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Haimin Weng
Institution:
Wenzhou Central Hospital
Observed institutions:
Zhejiang Chinese Medical University,
Zhejiang Cancer Hospital,
Wenzhou Central Hospital,
University of Chinese Academy of Sciences
ORCID:
0000-0002-0435-5824
Observed ORCID:
0000-0002-0435-5824
OpenAlex ID:
A5062266097
Evaluating first-line therapeutic strategies for metastatic castration-resistant prostate cancer: a comprehensive network meta-analysis and systematic review
2024
·
Duojie Zhang
, Haimin Weng
, et al.
·
Frontiers in Oncology
·
6
PDF
An Active Trend of Immunotherapy Combination Regimen as Second-Line Therapy Towards Advanced Biliary Tract Cancer
2024
·
Haimin Weng
, Pengfei Zeng
, et al.
·
Clinical Medicine Insights Oncology
·
3
Treatment selection for first- and second-line therapy and survival outcomes in advanced biliary tract cancer: A large real-world retrospective analysis.
2026
·
Yiwen Zhou
, Haimin Weng
, et al.
·
Journal of Clinical Oncology
PDF
Biliary Tract Cancer in Eastern China: A Multicenter Retrospective Analysis
2025
·
Yiwen Zhou
, Haimin Weng
, et al.
·
SSRN Electronic Journal
An active trend of immunotherapy combination regimen as second-line therapy for advanced biliary tract cancer: A multicenter retrospective study.
2023
·
Jieer Ying
, Haimin Weng
, et al.
·
Journal of Clinical Oncology
Abstract 5336: Dissecting the molecular mechanism of trastuzumab resistance in stage IV HER2-positive gastric cancer patients
2022
·
Qi Xu
, Jingjing Li
, et al.
·
Cancer Research
Show more works
View as search
Works count:
6
Citation count:
9
H-index:
2
I10-index:
Year
Topic
Type
